[Interpretation of Chinese guideline on the diagnosis and management of von Willebrand disease (2022)].
作者信息
Yin J, Yu Z Q
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2022 Jan 14;43(1):13-15. doi: 10.3760/cma.j.issn.0253-2727.2022.01.003.
Abstract
摘要
相似文献
1
[Interpretation of Chinese guideline on the diagnosis and management of von Willebrand disease (2022)].[《血管性血友病诊断和治疗中国指南（2022年版）》解读]
Zhonghua Xue Ye Xue Za Zhi. 2022 Jan 14;43(1):13-15. doi: 10.3760/cma.j.issn.0253-2727.2022.01.003.
2
[Chinese guideline on the diagnosis and management of von Willebrand disease (2022)].[2022年血管性血友病诊断与管理中国指南]
Zhonghua Xue Ye Xue Za Zhi. 2022 Jan 14;43(1):1-6. doi: 10.3760/cma.j.issn.0253-2727.2022.01.001.
3
[Inborn and acquired von Willebrand disease].[先天性和获得性血管性血友病]
Hamostaseologie. 2008 Dec;28(5):312-9.
4
Diagnosis of von Willebrand disease in people with type O blood.
Clin Adv Hematol Oncol. 2014 Feb;12(2):119-21.
5
von Willebrand Disease in Pediatrics: Evaluation and Management.儿童血管性血友病：评估与管理。
Hematol Oncol Clin North Am. 2019 Jun;33(3):425-438. doi: 10.1016/j.hoc.2019.01.010.
6
Advances in the diagnosis and management of von Willebrand disease.血管性血友病诊断与治疗的进展
Hematology. 2006 Aug;11(4):219-25. doi: 10.1080/10245330600841311.
7
Diagnosis and treatment of von Willebrand disease: new perspectives and nuances.
Haemophilia. 2007 Dec;13 Suppl 5:3-14. doi: 10.1111/j.1365-2516.2007.01581.x.
8
Diagnostic and therapeutic difficulties in type 2A von Willebrand disease: resolution.
Clin Appl Thromb Hemost. 2006 Apr;12(2):237-9. doi: 10.1177/107602960601200215.
9
Recognition and management of vascular lesions in von Willebrand disease.
J Thromb Haemost. 2021 Sep;19(9):2122-2124. doi: 10.1111/jth.15405.
10
Diagnosis and treatment of von Willebrand disease.血管性血友病的诊断与治疗
Hematol Oncol Clin North Am. 2004 Dec;18(6):1277-99, viii. doi: 10.1016/j.hoc.2004.07.006.
本文引用的文献
1
Bleeding assessment tools in the diagnosis of VWD in adults and children: a systematic review and meta-analysis of test accuracy.成人和儿童血管性血友病诊断中出血评估工具的系统评价和荟萃分析：对检测准确性的研究。
Blood Adv. 2021 Dec 14;5(23):5023-5031. doi: 10.1182/bloodadvances.2021004368.
2
von Willebrand disease: what does the future hold?血管性血友病：未来的前景如何？
Blood. 2021 Apr 29;137(17):2299-2306. doi: 10.1182/blood.2020008501.
3
Current Challenges in the Peripartum Management of Women with von Willebrand Disease.妊娠期和产褥期 von Willebrand 病妇女管理的当前挑战。
Semin Thromb Hemost. 2021 Mar;47(2):217-228. doi: 10.1055/s-0041-1723797. Epub 2021 Feb 26.
4
ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease.ASH ISTH NHF 2021 指南：关于血管性血友病的诊断。
Blood Adv. 2021 Jan 12;5(1):280-300. doi: 10.1182/bloodadvances.2020003265.
5
ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease.美国血液学会（ASH）、国际血栓与止血学会（ISTH）、美国国家血友病基金会（NHF）、世界血友病联盟（WFH）2021年血管性血友病管理指南
Blood Adv. 2021 Jan 12;5(1):301-325. doi: 10.1182/bloodadvances.2020003264.
6
How I treat von Willebrand disease.我如何治疗血管性血友病。
Thromb Res. 2020 Dec;196:618-625. doi: 10.1016/j.thromres.2020.07.051. Epub 2020 Aug 3.
7
Updated overview on von Willebrand disease: focus on the interest of genotyping.更新的血管性血友病概述：关注基因分型的意义。
Expert Rev Hematol. 2019 Dec;12(12):1023-1036. doi: 10.1080/17474086.2019.1670638. Epub 2019 Oct 6.
8
A personalized approach to the management of VWD.血管性血友病（VWD）管理的个性化方法。
Transfus Apher Sci. 2019 Oct;58(5):590-595. doi: 10.1016/j.transci.2019.08.009. Epub 2019 Aug 7.
9
Pregnancy and delivery in women with von Willebrand disease.妊娠与分娩：患有血管性血友病妇女的应对策略。
Eur J Haematol. 2019 Aug;103(2):73-79. doi: 10.1111/ejh.13250. Epub 2019 May 31.
10
Evaluation of the Utility of von Willebrand Factor Propeptide in the Differential Diagnosis of von Willebrand Disease and Acquired von Willebrand Syndrome.评价血管性血友病因子前肽在血管性血友病与获得性血管性血友病综合征鉴别诊断中的作用。
Semin Thromb Hemost. 2019 Feb;45(1):36-42. doi: 10.1055/s-0038-1660481. Epub 2018 Jun 18.
Zotero 插件